Abstract 1: Association of antithrombin levels with efficacy of fitusiran prophylaxis in people with hemophilia A or B with and without inhibitors: a predictive modeling approachAbstract 2: Annualized bleeding rates in hemophilia A/B and target joints: Concizumab explorer8 studyAbstract 3: Long-term efficacy of marstacimab in participants with severe hemophilia A or B without inhibitors

Ver todos los episodios